Outcome of Patients with Severe PH due to Lung Disease with and without Targeted Therapy

Summary Introduction Pulmonary hypertension (PH) can occur in patients with lung disease and worsen prognosis. Endothelin receptor antagonists, phosphodiesterase 5‐inhibitors, and prostacyclin analogs, referred to as targeted therapy, have not been shown in a limited number of controlled clinical st...

Ausführliche Beschreibung